Carolyn R. Aldigé

Carolyn R. ("Bo") Aldigé is president of the Prevent Cancer Foundation (formerly the Cancer Research and Prevention Foundation), a national non-profit organization she founded in 1985 in memory of her father, Edward P. Richardson, who died of cancer one year earlier. In the 23 years since its inception, Prevent Cancer has provided more than $106 million in support of its mission: cancer prevention and early detection through research, education, community-based programs and advocacy, and has become nationally recognized as a leader in the fight against cancer through prevention.

Ms. Aldigé is a member of the board of the National Coalition for Cancer Research, having served for eight years as its president. She also serves on boards of directors/advisors of six National Cancer Institute-designated Cancer Centers and as a member of the board of four additional non-profit cancer-related organizations. She has been a member of C-Change (formerly the National Dialogue on Cancer) since its inception. She serves on several key committees of this organization, as well as committees and task forces of the American Association for Cancer Research, the American Society of Clinical Oncology, the American Society of Preventive Oncology and the Coalition for a Stronger FDA. She is vice-chairman of the Global Lung Cancer Coalition and a member of the steering committees of the International Digestive Cancer Alliance and National Colorectal Cancer Roundtable. Ms. Aldigé is one of 25 individuals invited to serve on the Patient Advocate Advisory Council of Stand Up to Cancer, an unprecedented effort to raise private funds for cancer research.

For her many contributions to the Washington, DC community, Carolyn Aldigé was named a Washingtonian of the Year 1996. She is the only individual who has received Public Service Awards from the American Association for Cancer Research, the American Society of Clinical Oncology and the American Society of Preventive Oncology. She has been honored by numerous non-profit organizations and cancer centers, as well as the National Cancer Institute.

She has provided testimony both Houses of Congress and federal agencies and has been invited to speak on numerous occasions to lay and professional audiences, both nationally and internationally

<back